Inventor · disambiguated record
Nadima Uprety
Also filed as: UPRETY NADIMA
0 granted patents·10 pending applications·0 citations·filing 2021–2023
Files withUNIV TEXAS10
Top patents by PatentIndex Score
10 records- 0161US2025228942A1Methods for activation and expansion of engineered natural killer cells and combinations with antibodiesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0257US2025249098A1Cryopreservation of nk cell products for off-the-shelf immunotherapyUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0354US2025074950A1Methods for production of therapeutic immune cells having enhanced metabolic fitness and compositions thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0454US2024408203A1Engineering nk cells with a car construct with optimal signalingUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0554US2024252539A1Chimeric antigen receptor to target hla-g-positive cancersUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0653US2024325444A1Chimeric antigen receptor to target trop-2-positive cancersUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0753US2024269285A1Polypeptides targeting cd70-positive cancersUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0853US2024189357A1Chimeric antigen receptors to target cd5-positive cancersUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0952US2025281612A1Cd27-extracellular domain car to target cd70-positive tumorsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1048US2023210902A1Sars-cov-2-specific t cellsUNIV TEXAS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nadima Uprety files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →